Viewing Study NCT02770508


Ignite Creation Date: 2025-12-26 @ 10:56 AM
Ignite Modification Date: 2026-01-13 @ 12:45 PM
Study NCT ID: NCT02770508
Status: COMPLETED
Last Update Posted: 2018-08-03
First Post: 2015-11-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Darunavir/Ritonavir + Lamivudine Versus Darunavir/Ritonavir +Emtricitabine/Tenofovir in Naïve HIV-1 Infected Subjects
Sponsor: Fundación Huésped
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-11
Start Date Type: None
Primary Completion Date: 2017-07
Primary Completion Date Type: ACTUAL
Completion Date: 2017-10
Completion Date Type: ACTUAL
First Submit Date: 2015-11-16
First Submit QC Date: None
Study First Post Date: 2016-05-12
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-08-01
Last Update Post Date: 2018-08-03
Last Update Post Date Type: ACTUAL